Earnings Feed
Start Free
Home/Insiders/Ashe Andrew D.
AA
SEC Insider//CIK 0001573163

Ashe Andrew D.

CIK 00015731633 companiesBURLINGTON, MA
SEC Profile

Transactions

50

Companies

3

Filings

7

CIK

0001573163

Recent Transactions

50 trades
  • Disposition to Issuer
    Verve Therapeutics, Inc.

    Stock Option (right to buy)

    2025-07-25−225,000→ 0 total
  • Disposition to Issuer
    Verve Therapeutics, Inc.

    Restricted Stock Units

    2025-07-25−27,000→ 0 total
  • Disposition to Issuer
    Verve Therapeutics, Inc.

    Stock Option (right to buy)

    2025-07-25−26,999→ 0 total
  • Disposition from Tender
    Verve Therapeutics, Inc.

    Common Stock

    2025-07-25−348,828→ 0 total
  • Disposition to Issuer
    Verve Therapeutics, Inc.

    Stock Option (right to buy)

    2025-07-25−150,000→ 0 total
  • Disposition to Issuer
    Verve Therapeutics, Inc.

    Restricted Stock Units

    2025-07-25−40,000→ 0 total
  • Disposition to Issuer
    Verve Therapeutics, Inc.

    Stock Option (right to buy)

    2025-07-25−107,997→ 0 total
  • Disposition to Issuer
    Verve Therapeutics, Inc.

    Stock Option (right to buy)

    2025-07-25−153,278→ 0 total
  • Sale
    Verve Therapeutics, Inc.

    Common Stock

    2025-04-02$4.15/sh−2,681→ 348,828 total
  • Exercise/Conversion
    Verve Therapeutics, Inc.

    Restricted Stock Units

    2025-04-01−9,000→ 27,000 total
  • Exercise/Conversion
    Verve Therapeutics, Inc.

    Common Stock

    2025-04-01+9,000→ 351,509 total
  • Award
    Verve Therapeutics, Inc.

    Restricted Stock Units

    2025-01-08+40,000→ 40,000 total
  • Award
    Verve Therapeutics, Inc.

    Stock Option (right to buy)

    2025-01-08+225,000→ 225,000 total
  • Purchase
    Verve Therapeutics, Inc.

    Common Stock

    2024-05-14$6.26/sh+76,000→ 342,509 total
  • Award
    Verve Therapeutics, Inc.

    Stock Option (right to buy)

    2024-02-14+150,000→ 150,000 total
  • Award
    Verve Therapeutics, Inc.

    Restricted Stock Units

    2024-02-14+36,000→ 36,000 total
  • Award
    Verve Therapeutics, Inc.

    Stock Option (right to buy)

    2023-02-14+182,800→ 182,800 total
  • Exercise/Conversion
    Verve Therapeutics, Inc.

    Common Stock

    2022-08-25$1.39/sh+51,203→ 221,925 total
  • Exercise/Conversion
    Verve Therapeutics, Inc.

    Common Stock

    2022-08-25$2.87/sh+10,835→ 266,509 total
  • Exercise/Conversion
    Verve Therapeutics, Inc.

    Common Stock

    2022-08-25$1.48/sh+33,749→ 255,674 total
  • Exercise/Conversion
    Verve Therapeutics, Inc.

    Stock Option (right to buy)

    2022-08-25−51,203→ 0 total
  • Exercise/Conversion
    Verve Therapeutics, Inc.

    Stock Option (right to buy)

    2022-08-25−33,749→ 26,999 total
  • Exercise/Conversion
    Verve Therapeutics, Inc.

    Stock Option (right to buy)

    2022-08-25−10,835→ 153,278 total
  • Award
    Verve Therapeutics, Inc.

    Stock Option (right to buy)

    2022-02-11+125,000→ 125,000 total
  • Purchase
    Verve Therapeutics, Inc.

    Common Stock

    2021-12-02$32.10/sh+4,000→ 170,722 total
  • Award
    Verve Therapeutics, Inc.

    Stock Option (right to buy)

    2021-06-17+21,599→ 21,599 total
  • Award
    APPLIED GENETIC TECHNOLOGIES CORP

    Stock Option (right to buy)

    2017-08-01+100,000→ 100,000 total
  • Disposition to Issuer
    DYAX CORP

    Stock Option (right to buy)

    2016-01-22−237,500→ 0 total
  • Disposition to Issuer
    DYAX CORP

    Stock Option (right to buy)

    2016-01-22−78,000→ 0 total
  • Disposition to Issuer
    DYAX CORP

    Stock Option (right to buy)

    2016-01-22−23,437→ 0 total
  • Disposition to Issuer
    DYAX CORP

    Stock Option (right to buy)

    2016-01-22−20,312→ 0 total
  • Disposition to Issuer
    DYAX CORP

    Common Stock

    2016-01-22−331,528→ 0 total
  • Disposition to Issuer
    DYAX CORP

    Stock Option (right to buy)

    2016-01-22−18,125→ 0 total
  • Exercise/Conversion
    DYAX CORP

    Stock Option (right to buy)

    2016-01-14−66,000→ 78,000 total
  • Exercise/Conversion
    DYAX CORP

    Stock Option (right to buy)

    2016-01-14−51,563→ 23,437 total
  • Exercise/Conversion
    DYAX CORP

    Stock Option (right to buy)

    2016-01-14−38,750→ 18,125 total
  • Exercise/Conversion
    DYAX CORP

    Common Stock

    2016-01-14$1.87/sh+5,150→ 39,902 total
  • Exercise/Conversion
    DYAX CORP

    Common Stock

    2016-01-14$4.33/sh+51,563→ 203,028 total
  • Exercise/Conversion
    DYAX CORP

    Common Stock

    2016-01-14$1.48/sh+38,750→ 96,777 total
  • Exercise/Conversion
    DYAX CORP

    Common Stock

    2016-01-14$15.23/sh+62,500→ 331,528 total
  • Exercise/Conversion
    DYAX CORP

    Common Stock

    2016-01-14$2.39/sh+625→ 34,752 total
  • Exercise/Conversion
    DYAX CORP

    Common Stock

    2016-01-14$3.00/sh+54,688→ 151,465 total
  • Exercise/Conversion
    DYAX CORP

    Common Stock

    2016-01-14$10.20/sh+66,000→ 269,028 total
  • Exercise/Conversion
    DYAX CORP

    Stock Option (right to buy)

    2016-01-14−625→ 0 total
  • Exercise/Conversion
    DYAX CORP

    Stock Option (right to buy)

    2016-01-14−5,150→ 0 total
  • Exercise/Conversion
    DYAX CORP

    Stock Option (right to buy)

    2016-01-14−18,125→ 0 total
  • Exercise/Conversion
    DYAX CORP

    Common Stock

    2016-01-14$1.41/sh+18,125→ 58,027 total
  • Exercise/Conversion
    DYAX CORP

    Stock Option (right to buy)

    2016-01-14−38,750→ 17,565 total
  • Exercise/Conversion
    DYAX CORP

    Stock Option (right to buy)

    2016-01-14−54,688→ 20,312 total
  • Exercise/Conversion
    DYAX CORP

    Stock Option (right to buy)

    2016-01-14−51,563→ 23,437 total

Companies

3

Recent Filings

7

Address

C/O DYAX CORP. 55 NETWORK DRIVE

BURLINGTON, MA, 01803-2756

View on SEC.gov